The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global 3D Printed Drugs Market Outlook 2024

Global 3D Printed Drugs Market Outlook 2024

Publishing Date : Nov, 2021

License Type :
 

Report Code : 1632261

No of Pages : 93

Ask Your Query

Synopsis
3D Printed Drugs Market are medications, which are designed by 3D printing technique to customize for the individuals in a safer and effective way. 
Spritam is the only 3D printed drug which has received FDA approval. This drug was first available in the market in 2016, and can be used to treat epilepsy. 

The global 3D Printed Drugs market was valued at US$ 224.3 million in 2020 and is expected to reach US$ 297.8 million by the end of 2027, growing at a CAGR of 3.7% during 2021-2027.
This report focuses on 3D Printed Drugs volume and value at the global level, regional level and company level. From a global perspective, this report represents overall 3D Printed Drugs market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global 3D Printed Drugs Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

  • Spritam
  • Others

Segment by Application

  • Children
  • Elderly
  • Others

Consumption by Region

  • North America (United States, Canada, Mexico)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, Other Regions)
  • Europe (Germany, U.K., France, Italy, Russia, Rest of Europe)
  • South America (Brazil, Argentina, Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, U.A.E., South Africa, Other Regions)

By Company

  • Aprecia Pharmaceuticals
  • GlaxoSmithKline
  • Revolution Medicines
  • FabRX

 

Scope of the 3D Printed Drugs Market Report

Report Metric

Details

Report Name

3D Printed Drugs Market

Market size in 2021

US$ 224.3 Million

The revenue forecast in 2027

US$ 297.8 Million

Growth Rate

CAGR of 3.7% from 2021 to 2027

Market size available for years

2020-2027

Forecast units

Value (USD) & Volume (Units)

Segments covered

Types, End-User / Applications, Companies, and Region

Report coverage

Revenue & volume forecast, company share, competitive landscape, growth factors, and trends

Geographic regions covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

Index

1 3D Printed Drugs Market Overview
1.1 Product Overview and Scope of 3D Printed Drugs
1.2 3D Printed Drugs Segment by Type
1.2.1 Global 3D Printed Drugs Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Spritam
1.2.3 Others
1.3 3D Printed Drugs Segment by Application
1.3.1 Global 3D Printed Drugs Sales Comparison by Application: (2021-2027)
1.3.2 Children
1.3.3 Elderly
1.3.4 Others
1.4 Global 3D Printed Drugs Market Size Estimates and Forecasts
1.4.1 Global 3D Printed Drugs Revenue 2016-2027
1.4.2 Global 3D Printed Drugs Sales 2016-2027
1.4.3 3D Printed Drugs Market Size by Region: 2016 Versus 2021 Versus 2027

2 3D Printed Drugs Market Competition by Manufacturers
2.1 Global 3D Printed Drugs Sales Market Share by Manufacturers (2016-2021)
2.2 Global 3D Printed Drugs Revenue Market Share by Manufacturers (2016-2021)
2.3 Global 3D Printed Drugs Average Price by Manufacturers (2016-2021)
2.4 Manufacturers 3D Printed Drugs Manufacturing Sites, Area Served, Product Type
2.5 3D Printed Drugs Market Competitive Situation and Trends
2.5.1 3D Printed Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest 3D Printed Drugs Players Market Share by Revenue
2.5.3 Global 3D Printed Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 3D Printed Drugs Retrospective Market Scenario by Region
3.1 Global 3D Printed Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global 3D Printed Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America 3D Printed Drugs Market Facts & Figures by Country
3.3.1 North America 3D Printed Drugs Sales by Country
3.3.2 North America 3D Printed Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe 3D Printed Drugs Market Facts & Figures by Country
3.4.1 Europe 3D Printed Drugs Sales by Country
3.4.2 Europe 3D Printed Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific 3D Printed Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific 3D Printed Drugs Sales by Region
3.5.2 Asia Pacific 3D Printed Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America 3D Printed Drugs Market Facts & Figures by Country
3.6.1 Latin America 3D Printed Drugs Sales by Country
3.6.2 Latin America 3D Printed Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa 3D Printed Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa 3D Printed Drugs Sales by Country
3.7.2 Middle East and Africa 3D Printed Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global 3D Printed Drugs Historic Market Analysis by Type
4.1 Global 3D Printed Drugs Sales Market Share by Type (2016-2021)
4.2 Global 3D Printed Drugs Revenue Market Share by Type (2016-2021)
4.3 Global 3D Printed Drugs Price by Type (2016-2021)

5 Global 3D Printed Drugs Historic Market Analysis by Application
5.1 Global 3D Printed Drugs Sales Market Share by Application (2016-2021)
5.2 Global 3D Printed Drugs Revenue Market Share by Application (2016-2021)
5.3 Global 3D Printed Drugs Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Aprecia Pharmaceuticals
6.1.1 Aprecia Pharmaceuticals Corporation Information
6.1.2 Aprecia Pharmaceuticals Description and Business Overview
6.1.3 Aprecia Pharmaceuticals 3D Printed Drugs Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Aprecia Pharmaceuticals 3D Printed Drugs Product Portfolio
6.1.5 Aprecia Pharmaceuticals Recent Developments/Updates
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline Corporation Information
6.2.2 GlaxoSmithKline Description and Business Overview
6.2.3 GlaxoSmithKline 3D Printed Drugs Sales, Revenue and Gross Margin (2016-2021)
6.2.4 GlaxoSmithKline 3D Printed Drugs Product Portfolio
6.2.5 GlaxoSmithKline Recent Developments/Updates
6.3 Revolution Medicines
6.3.1 Revolution Medicines Corporation Information
6.3.2 Revolution Medicines Description and Business Overview
6.3.3 Revolution Medicines 3D Printed Drugs Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Revolution Medicines 3D Printed Drugs Product Portfolio
6.3.5 Revolution Medicines Recent Developments/Updates
6.4 FabRX
6.4.1 FabRX Corporation Information
6.4.2 FabRX Description and Business Overview
6.4.3 FabRX 3D Printed Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 FabRX 3D Printed Drugs Product Portfolio
6.4.5 FabRX Recent Developments/Updates

7 3D Printed Drugs Manufacturing Cost Analysis
7.1 3D Printed Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of 3D Printed Drugs
7.4 3D Printed Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 3D Printed Drugs Distributors List
8.3 3D Printed Drugs Customers

9 3D Printed Drugs Market Dynamics
9.1 3D Printed Drugs Industry Trends
9.2 3D Printed Drugs Growth Drivers
9.3 3D Printed Drugs Market Challenges
9.4 3D Printed Drugs Market Restraints

10 Global Market Forecast
10.1 3D Printed Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of 3D Printed Drugs by Type (2022-2027)
10.1.2 Global Forecasted Revenue of 3D Printed Drugs by Type (2022-2027)
10.2 3D Printed Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of 3D Printed Drugs by Application (2022-2027)
10.2.2 Global Forecasted Revenue of 3D Printed Drugs by Application (2022-2027)
10.3 3D Printed Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of 3D Printed Drugs by Region (2022-2027)
10.3.2 Global Forecasted Revenue of 3D Printed Drugs by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global 3D Printed Drugs Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global 3D Printed Drugs Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global 3D Printed Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers 3D Printed Drugs Covered in This Study
Table 5. Global 3D Printed Drugs Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global 3D Printed Drugs Sales Market Share by Manufacturers (2016-2021)
Table 7. Global 3D Printed Drugs Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global 3D Printed Drugs Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market 3D Printed Drugs Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers 3D Printed Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers 3D Printed Drugs Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global 3D Printed Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in 3D Printed Drugs as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global 3D Printed Drugs Sales by Region (2016-2021) & (K Units)
Table 16. Global 3D Printed Drugs Sales Market Share by Region (2016-2021)
Table 17. Global 3D Printed Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America 3D Printed Drugs Sales by Country (2016-2021) & (K Units)
Table 19. North America 3D Printed Drugs Sales Market Share by Country (2016-2021)
Table 20. North America 3D Printed Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America 3D Printed Drugs Revenue Market Share by Country (2016-2021)
Table 22. Europe 3D Printed Drugs Sales by Country (2016-2021) & (K Units)
Table 23. Europe 3D Printed Drugs Sales Market Share by Country (2016-2021)
Table 24. Europe 3D Printed Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe 3D Printed Drugs Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific 3D Printed Drugs Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific 3D Printed Drugs Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific 3D Printed Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific 3D Printed Drugs Revenue Market Share by Region (2016-2021)
Table 30. Latin America 3D Printed Drugs Sales by Country (2016-2021) & (K Units)
Table 31. Latin America 3D Printed Drugs Sales Market Share by Country (2016-2021)
Table 32. Latin America 3D Printed Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America 3D Printed Drugs Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa 3D Printed Drugs Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa 3D Printed Drugs Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa 3D Printed Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa 3D Printed Drugs Revenue Market Share by Country (2016-2021)
Table 38. Global 3D Printed Drugs Sales (K Units) by Type (2016-2021)
Table 39. Global 3D Printed Drugs Sales Market Share by Type (2016-2021)
Table 40. Global 3D Printed Drugs Revenue (Million US$) by Type (2016-2021)
Table 41. Global 3D Printed Drugs Revenue Share by Type (2016-2021)
Table 42. Global 3D Printed Drugs Price (USD/Unit) by Type (2016-2021)
Table 43. Global 3D Printed Drugs Sales (K Units) by Application (2016-2021)
Table 44. Global 3D Printed Drugs Sales Market Share by Application (2016-2021)
Table 45. Global 3D Printed Drugs Revenue (Million US$) by Application (2016-2021)
Table 46. Global 3D Printed Drugs Revenue Share by Application (2016-2021)
Table 47. Global 3D Printed Drugs Price (USD/Unit) by Application (2016-2021)
Table 48. Aprecia Pharmaceuticals Corporation Information
Table 49. Aprecia Pharmaceuticals Description and Business Overview
Table 50. Aprecia Pharmaceuticals 3D Printed Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Aprecia Pharmaceuticals 3D Printed Drugs Product
Table 52. Aprecia Pharmaceuticals Recent Developments/Updates
Table 53. GlaxoSmithKline Corporation Information
Table 54. GlaxoSmithKline Description and Business Overview
Table 55. GlaxoSmithKline 3D Printed Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. GlaxoSmithKline 3D Printed Drugs Product
Table 57. GlaxoSmithKline Recent Developments/Updates
Table 58. Revolution Medicines Corporation Information
Table 59. Revolution Medicines Description and Business Overview
Table 60. Revolution Medicines 3D Printed Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Revolution Medicines 3D Printed Drugs Product
Table 62. Revolution Medicines Recent Developments/Updates
Table 63. FabRX Corporation Information
Table 64. FabRX Description and Business Overview
Table 65. FabRX 3D Printed Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. FabRX 3D Printed Drugs Product
Table 67. FabRX Recent Developments/Updates
Table 68. Production Base and Market Concentration Rate of Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. 3D Printed Drugs Distributors List
Table 71. 3D Printed Drugs Customers List
Table 72. 3D Printed Drugs Market Trends
Table 73. 3D Printed Drugs Growth Drivers
Table 74. 3D Printed Drugs Market Challenges
Table 75. 3D Printed Drugs Market Restraints
Table 76. Global 3D Printed Drugs Sales Forecast by Type (2022-2027) & (K Units)
Table 77. Global 3D Printed Drugs Sales Market Share Forecast by Type (2022-2027)
Table 78. Global 3D Printed Drugs Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 79. Global 3D Printed Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 80. Global 3D Printed Drugs Sales Forecast by Application (2022-2027) & (K Units)
Table 81. Global 3D Printed Drugs Sales Market Share Forecast by Application (2022-2027)
Table 82. Global 3D Printed Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 83. Global 3D Printed Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 84. Global 3D Printed Drugs Sales Forecast by Region (2022-2027) & (K Units)
Table 85. Global 3D Printed Drugs Sales Market Share Forecast by Region (2022-2027)
Table 86. Global 3D Printed Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 87. Global 3D Printed Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of 3D Printed Drugs
Figure 2. Global 3D Printed Drugs Market Share by Type in 2020 & 2027
Figure 3. Spritam Product Picture
Figure 4. Others Product Picture
Figure 5. Global 3D Printed Drugs Market Share by Application in 2020 & 2027
Figure 6. Children
Figure 7. Elderly
Figure 8. Others
Figure 9. Global 3D Printed Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global 3D Printed Drugs Market Size 2016-2027 (US$ Million)
Figure 11. Global 3D Printed Drugs Sales 2016-2027 (K Units)
Figure 12. Global 3D Printed Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. 3D Printed Drugs Sales Share by Manufacturers in 2020
Figure 14. Global 3D Printed Drugs Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest 3D Printed Drugs Players: Market Share by Revenue in 2020
Figure 16. 3D Printed Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global 3D Printed Drugs Sales Market Share by Region (2016-2021)
Figure 18. Global 3D Printed Drugs Sales Market Share by Region in 2020
Figure 19. Global 3D Printed Drugs Revenue Market Share by Region (2016-2021)
Figure 20. Global 3D Printed Drugs Revenue Market Share by Region in 2020
Figure 21. U.S. 3D Printed Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada 3D Printed Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany 3D Printed Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France 3D Printed Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. 3D Printed Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy 3D Printed Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia 3D Printed Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China 3D Printed Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan 3D Printed Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea 3D Printed Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India 3D Printed Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia 3D Printed Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan 3D Printed Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia 3D Printed Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand 3D Printed Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia 3D Printed Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines 3D Printed Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam 3D Printed Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico 3D Printed Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil 3D Printed Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina 3D Printed Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey 3D Printed Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia 3D Printed Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. U.A.E 3D Printed Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of 3D Printed Drugs by Type (2016-2021)
Figure 46. Sales Market Share of 3D Printed Drugs by Application (2016-2021)
Figure 47. Sales Market Share of 3D Printed Drugs by Application in 2020
Figure 48. Revenue Share of 3D Printed Drugs by Application (2016-2021)
Figure 49. Revenue Share of 3D Printed Drugs by Application in 2020
Figure 50. Manufacturing Cost Structure of 3D Printed Drugs
Figure 51. Manufacturing Process Analysis of 3D Printed Drugs
Figure 52. 3D Printed Drugs Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock